» Articles » PMID: 9305846

Direct Stimulation of Bruton's Tyrosine Kinase by G(q)-protein Alpha-subunit

Overview
Journal Nature
Specialty Science
Date 1997 Sep 26
PMID 9305846
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Heterotrimeric guanine-nucleotide-binding regulatory proteins (G proteins) transduce signals from a wide variety of cell-surface receptors to generate physiological responses. Protein-tyrosine kinases are another group of critical cellular signal transducers and their malfunction often leads to cancer. Although activation of G-protein-coupled receptors can elicit rapid stimulation of cellular protein-tyrosine phosphorylation, the mechanism used by G proteins to activate protein-tyrosine kinases is unclear. Here we show that the purified alpha-subunit of the G(q) class of G proteins (G[alpha]q) directly stimulates the activity of a purified non-receptor kinase, Bruton's tyrosine kinase (Btk), whereas purified alpha-subunits from G(il), G(O) or G(z) proteins do not. G(alpha)q can also activate Btk in vivo. Furthermore, in Btk-deficient cells, stimulation of another kinase, a p38 MAP kinase, by Gq-coupled receptors is blocked. Our results demonstrate that certain protein-tyrosine kinases can be direct effectors of G proteins.

Citing Articles

CXCR4 as a therapeutic target in acute myeloid leukemia.

Korbecki J, Bosiacki M, Kupnicka P, Barczak K, Chlubek D, Baranowska-Bosiacka I Leukemia. 2024; 38(11):2303-2317.

PMID: 39261603 DOI: 10.1038/s41375-024-02326-3.


New Means and Challenges in the Targeting of BTK.

Nawaratne V, Sondhi A, Abdel-Wahab O, Taylor J Clin Cancer Res. 2024; 30(11):2333-2341.

PMID: 38578606 PMC: 11147694. DOI: 10.1158/1078-0432.CCR-23-0409.


GNA15 facilitates the malignant development of thyroid carcinoma cells via the BTK-mediated MAPK signaling pathway.

Sun Y, Han Y Histol Histopathol. 2024; 39(9):1217-1227.

PMID: 38333922 DOI: 10.14670/HH-18-714.


Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.

Park H, Chae M, Ko J, Kikkawa D, Jang S, Yoon J PLoS One. 2022; 17(12):e0279060.

PMID: 36521376 PMC: 9754806. DOI: 10.1371/journal.pone.0279060.


Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.

von Suskil M, Sultana K, Elbezanti W, Al-Odat O, Chitren R, Tiwari A Int J Mol Sci. 2021; 22(11).

PMID: 34071917 PMC: 8198777. DOI: 10.3390/ijms22115707.